Ozanimod

CAS No.

1306760-87-1

MDL No.

MFCD28386168

C₂₃H₂₄N₄O₃

404.50

InChI Key

XRVDGNKRPOAQTN-FQEVSTJZSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

Ozanimod is a sphingosine 1-phosphate receptor modulator under investigation for the treatment of Multiple Sclerosis (MS) and inflammatory bowel disease (IBD).

CAS No.	1306760-87-1
Product Name	Ozanimod

Biological Targets

S1PR5·S1PR1

Associated Conditions

relapsing-remitting multiple sclerosis·ulcerative colitis·COVID-19·liver disease·Crohn's disease·

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Documentation

Ozanimod

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Related Articles

Amiselimod (MT-1303), a novel sphingosine 1-phosphate receptor-1 functional antagonist, inhibits progress of chronic colitis induced by transfer of CD4+CD45RBhigh T cells.

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial.

Ozanimod (RPC1063), a selective S1PR1 and S1PR5 modulator, reduces chronic inflammation and alleviates kidney pathology in murine systemic lupus erythematosus.

Effects of High- and Low-Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator.

Documentation

Similar Products

Ozanimod Hydrochloride

tert-butyl N-[(1S)-4-[5-(3-cyano-4-isopropoxy-phenyl)-1,2,4-oxadiazol-3-yl]indan-1-yl]carbamate